TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 20 October 15, 2012
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 20 October 15, 2012
(The next issue will be on November 1, 2012)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1FOX0jiy08bdn0oftutiDpz/
Agerso H, Tranholm M (2012) Pharmacokinetics and pharmacodynamics of rFVIIa and new improved bypassing agents for the treatment of haemophilia. Haemophilia 18 Suppl 5:6-10.
http://www.ncbi.nlm.nih.gov/pubmed/22757678
Astrup E, Lekva T, Davi G, Otterdal K, Santilli F, Oie E, . . . Aukrust P (2012) A Complex Interaction between Rickettsia conorii and Dickkopf-1 - Potential Role in Immune Evasion Mechanisms in Endothelial Cells. PLoS One 7:e43638.
http://www.ncbi.nlm.nih.gov/pubmed/23028464
Bastarache JA, Sebag SC, Clune JK, Grove BS, Lawson WE, Janz DR, . . . Ware LB (2012) Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress. Thorax.
http://www.ncbi.nlm.nih.gov/pubmed/23033361
Bonnet MP, Basso O (2012) Prohemostatic interventions in obstetric hemorrhage. Semin Thromb Hemost 38:259-264.
http://www.ncbi.nlm.nih.gov/pubmed/22510859
Caviglia H, Narayan P, Forsyth A, Giangrande P, Gilbert M, Goddard N, . . . Rahim S (2012) Musculoskeletal problems in persons with inhibitors: how do we treat? Haemophilia 18 Suppl 4:54-60.
http://www.ncbi.nlm.nih.gov/pubmed/22726084
Cesarman-Maus G, Braggio E, Maldonado H, Fonseca R (2012) Absence of tissue factor expression by neoplastic plasma cells in multiple myeloma. Leukemia 26:1671-1674.
http://www.ncbi.nlm.nih.gov/pubmed/22333877
Chantrathammachart P, Mackman N, Sparkenbaugh E, Wang JG, Parise LV, Kirchhofer D, . . . Pawlinski R (2012) Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease. Blood 120:636-646.
http://www.ncbi.nlm.nih.gov/pubmed/22661702
Chitlur M (2012) Challenges in the laboratory analyses of bleeding disorders. Thromb Res 130:1-6.
http://www.ncbi.nlm.nih.gov/pubmed/22483776
Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebo R, Kierulf P, . . . Sandset PM (2012) A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women. Thromb Res 130:45-51.
http://www.ncbi.nlm.nih.gov/pubmed/22217510
Guzzetta NA, Russell IA, Williams GD (2012) Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. Anesth Analg 115:364-378.
http://www.ncbi.nlm.nih.gov/pubmed/22652310
Howard BM, Daley AT, Cohen MJ (2012) Prohemostatic interventions in trauma: resuscitation-associated coagulopathy, acute traumatic coagulopathy, hemostatic resuscitation, and other hemostatic interventions. Semin Thromb Hemost 38:250-258.
http://www.ncbi.nlm.nih.gov/pubmed/22467527
Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV (2011) Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. J Perinat Med 40:43-49.
http://www.ncbi.nlm.nih.gov/pubmed/22017328
Kambas K, Mitroulis I, Apostolidou E, Girod A, Chrysanthopoulou A, Pneumatikos I, . . . Ritis K (2012) Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis. PLoS One 7:e45427.
http://www.ncbi.nlm.nih.gov/pubmed/23029002
Kandane-Rathnayake RK, Isbister JP, Zatta AJ, Aoki NJ, Cameron P, Phillips LE (2012) Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding. ANZ J Surg.
http://www.ncbi.nlm.nih.gov/pubmed/23035873
Kim G, Kim H, Kim KN, Son JI, Kim SY, Tamura T, Chang N (2012) Relationship of Cognitive Function with B Vitamin Status, Homocysteine, and Tissue Factor Pathway Inhibitor in Cognitively Impaired Elderly: A Cross-Sectional Survey. J Alzheimers Dis.
http://www.ncbi.nlm.nih.gov/pubmed/23042212
Kim JE, Kim KJ, Ahn W, Han KS, Kim HK (2011) Local anesthetics inhibit tissue factor expression in activated monocytes via inhibition of tissue factor mRNA synthesis. Clin Appl Thromb Hemost 17:E4-9.
http://www.ncbi.nlm.nih.gov/pubmed/20699252
Kogiso N, Taki M, Takamiya O (2011) Factor VII deficiency due to compound heterozygosity for Leu-48Pro mutation and a novel Pro260Leu mutation. Clin Appl Thromb Hemost 17:E205-210.
http://www.ncbi.nlm.nih.gov/pubmed/21441234
Koizume S, Ito S, Miyagi E, Hirahara F, Nakamura Y, Sakuma Y, . . . Miyagi Y (2012) HIF2alpha-Sp1 interaction mediates a deacetylation-dependent FVII-gene activation under hypoxic conditions in ovarian cancer cells. Nucleic Acids Res 40:5389-5401.
http://www.ncbi.nlm.nih.gov/pubmed/22402494
Kothari H, Rao LV, Vankayalapati R, Pendurthi UR (2012) Mycobacterium tuberculosis Infection and Tissue Factor Expression in Macrophages. PLoS One 7:e45700.
http://www.ncbi.nlm.nih.gov/pubmed/23029190
Kubier A, O'Brien M (2012) Endogenous anticoagulants. Top Companion Anim Med 27:81-87.
http://www.ncbi.nlm.nih.gov/pubmed/23031460
Lee AM, Tormoen GW, Kanso E, McCarty OJ, Newton PK (2012) Modeling and Simulation of Procoagulant Circulating Tumor Cells in Flow. Front Oncol 2:108.
http://www.ncbi.nlm.nih.gov/pubmed/23050240
Levy JH, Sniecinski RM (2012) Prohemostatic treatment in cardiac surgery. Semin Thromb Hemost 38:237-243.
http://www.ncbi.nlm.nih.gov/pubmed/22510857
Monroe DM, Hoffman M (2012) The clotting system - a major player in wound healing. Haemophilia 18 Suppl 5:11-16.
http://www.ncbi.nlm.nih.gov/pubmed/22757679
O'Brien M (2012) The reciprocal relationship between inflammation and coagulation. Top Companion Anim Med 27:46-52.
http://www.ncbi.nlm.nih.gov/pubmed/23031455
Peled E, Rovitsky A, Axelman E, Norman D, Brenner B, Nadir Y (2012) Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin. Thromb Res 130:129-134.
http://www.ncbi.nlm.nih.gov/pubmed/22154361
Persson E, Olsen OH, Bjorn SE, Ezban M (2012) Vatreptacog alfa from conception to clinical proof of concept. Semin Thromb Hemost 38:274-281.
http://www.ncbi.nlm.nih.gov/pubmed/22510860
Peyvandi F, Bolton-Maggs PH, Batorova A, De Moerloose P (2012) Rare bleeding disorders. Haemophilia 18 Suppl 4:148-153.
http://www.ncbi.nlm.nih.gov/pubmed/22726099
Ranucci M, Baryshnikova E, Colella D (2012) Monitoring prohemostatic treatment in bleeding patients. Semin Thromb Hemost 38:282-291.
http://www.ncbi.nlm.nih.gov/pubmed/22510861
Sanchez-Solana B, Motwani M, Li DQ, Eswaran J, Kumar R (2012) P21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor. J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/23038262
Seligsohn U (2012) Treatment of inherited platelet disorders. Haemophilia 18 Suppl 4:161-165.
http://www.ncbi.nlm.nih.gov/pubmed/22726101
Shibeko AM, Woodle SA, Lee TK, Ovanesov MV (2012) Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids. Blood 120:891-899.
http://www.ncbi.nlm.nih.gov/pubmed/22563088
Stellingwerff M, Brandsma A, Lisman T, Porte RJ (2012) Prohemostatic interventions in liver surgery. Semin Thromb Hemost 38:244-249.
http://www.ncbi.nlm.nih.gov/pubmed/22510858
Stepien E, Kablak-Ziembicka A, Czyz J, Przewlocki T, Malecki M (2012) Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging. Expert Opin Ther Targets 16:677-688.
http://www.ncbi.nlm.nih.gov/pubmed/22616736
Vadivel K, Bajaj SP (2012) Structural biology of factor VIIa/tissue factor initiated coagulation. Front Biosci 17:2476-2494.
http://www.ncbi.nlm.nih.gov/pubmed/22652793
Vaitkiene P, Skiriute D, Skauminas K, Tamasauskas A (2012) Associations Between TFPI-2 Methylation and Poor Prognosis in Glioblastomas. Medicina (Kaunas) 48:345-349.
http://www.ncbi.nlm.nih.gov/pubmed/23032906
Vanden Hoek AL, Talbot K, Carter IS, Vickars L, Carter CJ, Jackson SC, . . . Pryzdial EL (2012) Coagulation Factor X Arg386 specifically affects activation by the intrinsic pathway: A novel patient mutation. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23039000
von Kanel R, Natarajan L, Ancoli-Israel S, Mills PJ, Wolfson T, Gamst AC, . . . Dimsdale JE (2012) Effect of continuous positive airway pressure on day/night rhythm of prothrombotic markers in obstructive sleep apnea. Sleep Med.
http://www.ncbi.nlm.nih.gov/pubmed/23036264
__________________________________________________________
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1FOX0jiy08bdn0oftutiDpz/
Agerso H, Tranholm M (2012) Pharmacokinetics and pharmacodynamics of rFVIIa and new improved bypassing agents for the treatment of haemophilia. Haemophilia 18 Suppl 5:6-10.
http://www.ncbi.nlm.nih.gov/pubmed/22757678
Astrup E, Lekva T, Davi G, Otterdal K, Santilli F, Oie E, . . . Aukrust P (2012) A Complex Interaction between Rickettsia conorii and Dickkopf-1 - Potential Role in Immune Evasion Mechanisms in Endothelial Cells. PLoS One 7:e43638.
http://www.ncbi.nlm.nih.gov/pubmed/23028464
Bastarache JA, Sebag SC, Clune JK, Grove BS, Lawson WE, Janz DR, . . . Ware LB (2012) Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress. Thorax.
http://www.ncbi.nlm.nih.gov/pubmed/23033361
Bonnet MP, Basso O (2012) Prohemostatic interventions in obstetric hemorrhage. Semin Thromb Hemost 38:259-264.
http://www.ncbi.nlm.nih.gov/pubmed/22510859
Caviglia H, Narayan P, Forsyth A, Giangrande P, Gilbert M, Goddard N, . . . Rahim S (2012) Musculoskeletal problems in persons with inhibitors: how do we treat? Haemophilia 18 Suppl 4:54-60.
http://www.ncbi.nlm.nih.gov/pubmed/22726084
Cesarman-Maus G, Braggio E, Maldonado H, Fonseca R (2012) Absence of tissue factor expression by neoplastic plasma cells in multiple myeloma. Leukemia 26:1671-1674.
http://www.ncbi.nlm.nih.gov/pubmed/22333877
Chantrathammachart P, Mackman N, Sparkenbaugh E, Wang JG, Parise LV, Kirchhofer D, . . . Pawlinski R (2012) Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease. Blood 120:636-646.
http://www.ncbi.nlm.nih.gov/pubmed/22661702
Chitlur M (2012) Challenges in the laboratory analyses of bleeding disorders. Thromb Res 130:1-6.
http://www.ncbi.nlm.nih.gov/pubmed/22483776
Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebo R, Kierulf P, . . . Sandset PM (2012) A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women. Thromb Res 130:45-51.
http://www.ncbi.nlm.nih.gov/pubmed/22217510
Guzzetta NA, Russell IA, Williams GD (2012) Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. Anesth Analg 115:364-378.
http://www.ncbi.nlm.nih.gov/pubmed/22652310
Howard BM, Daley AT, Cohen MJ (2012) Prohemostatic interventions in trauma: resuscitation-associated coagulopathy, acute traumatic coagulopathy, hemostatic resuscitation, and other hemostatic interventions. Semin Thromb Hemost 38:250-258.
http://www.ncbi.nlm.nih.gov/pubmed/22467527
Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV (2011) Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. J Perinat Med 40:43-49.
http://www.ncbi.nlm.nih.gov/pubmed/22017328
Kambas K, Mitroulis I, Apostolidou E, Girod A, Chrysanthopoulou A, Pneumatikos I, . . . Ritis K (2012) Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis. PLoS One 7:e45427.
http://www.ncbi.nlm.nih.gov/pubmed/23029002
Kandane-Rathnayake RK, Isbister JP, Zatta AJ, Aoki NJ, Cameron P, Phillips LE (2012) Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding. ANZ J Surg.
http://www.ncbi.nlm.nih.gov/pubmed/23035873
Kim G, Kim H, Kim KN, Son JI, Kim SY, Tamura T, Chang N (2012) Relationship of Cognitive Function with B Vitamin Status, Homocysteine, and Tissue Factor Pathway Inhibitor in Cognitively Impaired Elderly: A Cross-Sectional Survey. J Alzheimers Dis.
http://www.ncbi.nlm.nih.gov/pubmed/23042212
Kim JE, Kim KJ, Ahn W, Han KS, Kim HK (2011) Local anesthetics inhibit tissue factor expression in activated monocytes via inhibition of tissue factor mRNA synthesis. Clin Appl Thromb Hemost 17:E4-9.
http://www.ncbi.nlm.nih.gov/pubmed/20699252
Kogiso N, Taki M, Takamiya O (2011) Factor VII deficiency due to compound heterozygosity for Leu-48Pro mutation and a novel Pro260Leu mutation. Clin Appl Thromb Hemost 17:E205-210.
http://www.ncbi.nlm.nih.gov/pubmed/21441234
Koizume S, Ito S, Miyagi E, Hirahara F, Nakamura Y, Sakuma Y, . . . Miyagi Y (2012) HIF2alpha-Sp1 interaction mediates a deacetylation-dependent FVII-gene activation under hypoxic conditions in ovarian cancer cells. Nucleic Acids Res 40:5389-5401.
http://www.ncbi.nlm.nih.gov/pubmed/22402494
Kothari H, Rao LV, Vankayalapati R, Pendurthi UR (2012) Mycobacterium tuberculosis Infection and Tissue Factor Expression in Macrophages. PLoS One 7:e45700.
http://www.ncbi.nlm.nih.gov/pubmed/23029190
Kubier A, O'Brien M (2012) Endogenous anticoagulants. Top Companion Anim Med 27:81-87.
http://www.ncbi.nlm.nih.gov/pubmed/23031460
Lee AM, Tormoen GW, Kanso E, McCarty OJ, Newton PK (2012) Modeling and Simulation of Procoagulant Circulating Tumor Cells in Flow. Front Oncol 2:108.
http://www.ncbi.nlm.nih.gov/pubmed/23050240
Levy JH, Sniecinski RM (2012) Prohemostatic treatment in cardiac surgery. Semin Thromb Hemost 38:237-243.
http://www.ncbi.nlm.nih.gov/pubmed/22510857
Monroe DM, Hoffman M (2012) The clotting system - a major player in wound healing. Haemophilia 18 Suppl 5:11-16.
http://www.ncbi.nlm.nih.gov/pubmed/22757679
O'Brien M (2012) The reciprocal relationship between inflammation and coagulation. Top Companion Anim Med 27:46-52.
http://www.ncbi.nlm.nih.gov/pubmed/23031455
Peled E, Rovitsky A, Axelman E, Norman D, Brenner B, Nadir Y (2012) Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin. Thromb Res 130:129-134.
http://www.ncbi.nlm.nih.gov/pubmed/22154361
Persson E, Olsen OH, Bjorn SE, Ezban M (2012) Vatreptacog alfa from conception to clinical proof of concept. Semin Thromb Hemost 38:274-281.
http://www.ncbi.nlm.nih.gov/pubmed/22510860
Peyvandi F, Bolton-Maggs PH, Batorova A, De Moerloose P (2012) Rare bleeding disorders. Haemophilia 18 Suppl 4:148-153.
http://www.ncbi.nlm.nih.gov/pubmed/22726099
Ranucci M, Baryshnikova E, Colella D (2012) Monitoring prohemostatic treatment in bleeding patients. Semin Thromb Hemost 38:282-291.
http://www.ncbi.nlm.nih.gov/pubmed/22510861
Sanchez-Solana B, Motwani M, Li DQ, Eswaran J, Kumar R (2012) P21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor. J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/23038262
Seligsohn U (2012) Treatment of inherited platelet disorders. Haemophilia 18 Suppl 4:161-165.
http://www.ncbi.nlm.nih.gov/pubmed/22726101
Shibeko AM, Woodle SA, Lee TK, Ovanesov MV (2012) Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids. Blood 120:891-899.
http://www.ncbi.nlm.nih.gov/pubmed/22563088
Stellingwerff M, Brandsma A, Lisman T, Porte RJ (2012) Prohemostatic interventions in liver surgery. Semin Thromb Hemost 38:244-249.
http://www.ncbi.nlm.nih.gov/pubmed/22510858
Stepien E, Kablak-Ziembicka A, Czyz J, Przewlocki T, Malecki M (2012) Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging. Expert Opin Ther Targets 16:677-688.
http://www.ncbi.nlm.nih.gov/pubmed/22616736
Vadivel K, Bajaj SP (2012) Structural biology of factor VIIa/tissue factor initiated coagulation. Front Biosci 17:2476-2494.
http://www.ncbi.nlm.nih.gov/pubmed/22652793
Vaitkiene P, Skiriute D, Skauminas K, Tamasauskas A (2012) Associations Between TFPI-2 Methylation and Poor Prognosis in Glioblastomas. Medicina (Kaunas) 48:345-349.
http://www.ncbi.nlm.nih.gov/pubmed/23032906
Vanden Hoek AL, Talbot K, Carter IS, Vickars L, Carter CJ, Jackson SC, . . . Pryzdial EL (2012) Coagulation Factor X Arg386 specifically affects activation by the intrinsic pathway: A novel patient mutation. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23039000
von Kanel R, Natarajan L, Ancoli-Israel S, Mills PJ, Wolfson T, Gamst AC, . . . Dimsdale JE (2012) Effect of continuous positive airway pressure on day/night rhythm of prothrombotic markers in obstructive sleep apnea. Sleep Med.
http://www.ncbi.nlm.nih.gov/pubmed/23036264
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
